← FDA Drug Approvals (Drugs@FDA)
ARNUITY ELLIPTA
NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2014-08-20
Drug application
- FDA Application #
NDA205625
- Application type
- New Drug Application
- Brand name
- ARNUITY ELLIPTA
- Generic name
- FLUTICASONE FUROATE
- Active ingredients
- FLUTICASONE FUROATE
- Dosage form
- POWDER
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE
- Manufacturer
- Prasco Laboratories
- First approval
- 2014-08-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown